Home
>
Assessments
>
Device-Guided Controlled Breathing as a Treatment for Hypertension
Device-Guided Controlled Breathing as a Treatment for Hypertension
| Please note: All assessments are current as of the review date; however, new evidence that may have been published subsequently is not considered. |
| Review Date: |
October 18, 2006 |
| Recommendation: |
This topic was reviewed by the California Technology Assessment Forum on October 18, 2006. It was recommended that daily use of RESPeRATE for device-guided breathing to lower systolic blood pressure as adjunctive treatment for patients with persistently high blood pressure in the Stage I or II range, and who are otherwise healthy, non-pregnant individuals meets CTAF Criteria. |
| Decision: |
Does Meet CTAF Criteria |
| Full Assessment: |
Download (PDF) |
|
|
© 2009 California Technology Assessment Forum. All rights reserved.